Safety and dosimetry of 177Lu-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer

Jie Zang; Hao Wang; Qingxing Liu; Orit Jacobson; Gang Niu; Zhaohui Zhu; Xiaoyuan Chen

Meeting ReportMolecular Targeting Probes Track

Safety and dosimetry of ¹⁷⁷Lu-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer

Jie Zang, Hao Wang, Qingxing Liu, Orit Jacobson, Gang Niu, Zhaohui Zhu and Xiaoyuan Chen

Journal of Nuclear Medicine May 2018, 59 (supplement 1) 140;

Jie Zang

6Peking Union Medical College Hospital Beijing China

7Peking Union Medical College Hospital Beijing China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hao Wang

6Peking Union Medical College Hospital Beijing China

7Peking Union Medical College Hospital Beijing China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Qingxing Liu

1Beijing China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Orit Jacobson

29000 Rockville Pike Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gang Niu

5NIH Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zhaohui Zhu

3Department of Nuclear Medicine, Peking Union Medic Beijing China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiaoyuan Chen

4NIBIB/NIH Bethesda MD United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint
Download figure
Open in new tab
Download powerpoint

In this issue

Journal of Nuclear Medicine

Vol. 59, Issue supplement 1

May 1, 2018

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Safety and dosimetry of 177Lu-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Safety and dosimetry of ¹⁷⁷Lu-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer

Jie Zang, Hao Wang, Qingxing Liu, Orit Jacobson, Gang Niu, Zhaohui Zhu, Xiaoyuan Chen

Journal of Nuclear Medicine May 2018, 59 (supplement 1) 140;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Safety and dosimetry of ¹⁷⁷Lu-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer

Jie Zang, Hao Wang, Qingxing Liu, Orit Jacobson, Gang Niu, Zhaohui Zhu, Xiaoyuan Chen

Journal of Nuclear Medicine May 2018, 59 (supplement 1) 140;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

Molecular Targeting Probes Track

Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [¹⁸F]IUR-1601
In vivo evaluation of [²²⁵Ac]Ac-DOTA^ZOL for α-therapy of bone metastases
Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry

Show more Molecular Targeting Probes Track

Clinical Dosimetry

Optimal sampling schedule for dosimetry: A simulation study.
Preclinical radiation dose optimization, dosimetry and maximum tolerated dose studies of Lu-177-labeled CTT1403, a phosphoramidate-based PSMA inhibitor for targeted radionuclide therapy of prostate cancer.

Show more Clinical Dosimetry

Main menu

User menu

Search

Safety and dosimetry of ¹⁷⁷Lu-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer

Article Figures & Data

Figures

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Molecular Targeting Probes Track

Clinical Dosimetry

Similar Articles